Broadly, mice that exhibit Aβ plaque formation via human APP and human PS1, but not pTau neurofibrillary tangles, exhibit varying circadian alterations but do not reliably recapitulate the neurodegeneration nor the specific circadian dysfunction seen in AD patients. The gene discussed is APP; the disease is Alzheimer disease.